A retrospective, single center study investigating safety and efficacy of trastuzumab emtansine in patients with HER2 positive advanced breast cancer
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Nov 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress